nach oben

Administration and Policy in Mental Health and Mental Health Services Research

Erschienen in:

01.03.2006

An Economic Comparison of Risperidone and Olanzapine Use within an Integrated Managed Mental Health Program

verfasst von: Michael Johnsrud, M. Lynn. Crismon, Ann Thompson, Amy Grogg

Erschienen in: Administration and Policy in Mental Health and Mental Health Services Research | Ausgabe 2/2006

Einloggen, um Zugang zu erhalten

This study assessed differences in total mental health care costs for 1 year following initiation of risperidone or olanzapine in individuals within NorthSTAR, an integrated managed mental health pilot project. A retrospective database analysis of individuals with schizophrenia or schizoaffective disorder and newly started on either agent was conducted. Antipsychotic medication costs were significantly lower for individuals prescribed risperidone than olanzapine ($1763 versus $2582; p<0.001). Individuals prescribed risperidone had lower (but not significant) expenditures for mental health services ($4714 versus $5077; p=0.792), as well as total mental health care costs ($7407 versus $9011; p=0.255).

American Psychiatric Association. Practice. (2004). Guideline for the treatment of patients with schizophrenia: second edition. February 2004. Arlington, VA

Baker J (2001) Engaging the community mental health stakeholders in pharmacy cost management. Psychiatric Services 52:650–3PubMedCrossRef

Bhana N, Foster RH, Olney R, et al (2001) Olanzapine: An update review of its use in the management of schizophrenia. Drugs 61:111–61PubMedCrossRef

Buck J (2001) Managed mental health care in Medicaid: Does the solution match the problem? Administration and Policy in Mental Health 29:177–80PubMedCrossRef

Crown WH, Neslusan C, Russo PA, et al. (2001) Hospitalization and total medical costs for privately insured persons with schizophrenia. Administration and Policy in Mental Health 28:335–51PubMedCrossRef

Fuller MA, Shermock KM, Secic M, et al (2002) Service use and costs among VA patients with schizophrenia taking risperidone or olanzapine. Psychiatric Services 53:855–60PubMedCrossRef

Kasper S, Jones M, Duchesne I (2001) Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): health economic results of an international naturalistic study. International Clinical Psychopharmacology 16:189–96PubMedCrossRef

Kelly DL, Nelson MW, Love RC, et al (2001) Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine. Psychiatric Services 52:676–8PubMedCrossRef

Lewis M, McCrone P, Frangou S (2001) Service use and costs of treating schizophrenia with atypical antipsychotics. Journal of Clinical Psychiatry 62:749–56PubMed

Liu GG, Sun SX, Christensen DB, et al. (2004) Cost comparisons of olanzapine and risperidone in treating schizophrenia. Annals of Pharmacotherapy 38: 134–141PubMedCrossRef

McFarland BH, Khorramzadeh S, Millins R, et al (2002) Psychiatric hospital length of stay for Medicaid clients before and after managed care. Administration and Policy in Mental Health 29:191–9PubMedCrossRef

Miller AL, Hall CS, Buchanan RW, et al (2004) The Texas Medication Algorithm Project: antipsychotic algorithm for schizophrenia: 2003 update. Journal of Clinical Psychiatry 65 (4): 500–8PubMedCrossRef

Prochshyn RM, Zerjav S (1998) Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone or olanzapine. Clinical Therapeutics 20:1203–17CrossRef

Rabinowitz J, Lichtenberg P, Kaplan Z (2000) Comparison of cost, dosage and clinical preference for risperidone and olanzapine.Schizophrenia Research 46:91–6PubMedCrossRef

Sturm R, Jackson CA, Meredith LS, et al (1995) Mental health care utilization in prepaid and fee-for-service plans among depressed patients in the Medical Outcomes Study. Health Services Research 30:319–40PubMed

Texas Health and Human Services Commission. (1999). Press Release, September 14, Austin, TX.

Zhao Z (2002) A retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia. Managed Care Interface 15:75–81PubMed

Titel: An Economic Comparison of Risperidone and Olanzapine Use within an Integrated Managed Mental Health Program
verfasst von: Michael Johnsrud
M. Lynn. Crismon
Ann Thompson
Amy Grogg
Publikationsdatum: 01.03.2006
Verlag: Springer US
Erschienen in: Administration and Policy in Mental Health and Mental Health Services Research / Ausgabe 2/2006
Print ISSN: 0894-587X
Elektronische ISSN: 1573-3289
DOI: https://doi.org/10.1007/s10488-005-0018-y

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2006

Residential Mobility and Severe Mental Illness: A Population-based Analysis

Poor and Depressed, The Tip of the Iceberg: The Unmet Needs of Enrollees in an Indigent Health Care Plan

Management of Mental Disorders in VA Primary Care Practices

The Use of Housing as Leverage to Increase Adherence to Psychiatric Treatment in the Community

School-Based Mental Health Services for Children Living in High Poverty Urban Communities